Related Experiment Videos
Prostate cancer: where are we and where are we going?
1Johns Hopkins Oncology Centre, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
British Journal of Urology
|March 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
LSD1 inhibition suppresses ASCL1 and de-represses YAP1 to drive potent activity against neuroendocrine prostate cancer.
bioRxiv : the preprint server for biology·2024
The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancer.
Prostate cancer and prostatic diseases·2016
The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer.
Prostate cancer and prostatic diseases·2013
Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management.
Journal of the National Cancer Institute·2026
Periductal myxoid stroma identifies ductal carcinoma in situ at risk of invasive recurrence.
Journal of the National Cancer Institute·2026
Survival outcomes of expansile versus infiltrative subtype in primary mucinous ovarian carcinomas: A retrospective study in Thailand.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Risk factors for local recurrence and metastasis of eyelid sebaceous carcinoma after complete excision: A large cohort study in Japan.
Indian journal of ophthalmology·2026